{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:33:53Z","timestamp":1792690433938,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019268","name":"Showa University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jphs.2024.12.004","type":"journal-article","created":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T02:09:23Z","timestamp":1734228563000},"page":"57-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["SMTP-44D alleviates diabetic retinopathy by suppressing inflammation and oxidative stress in in vivo and in vitro models"],"prefix":"10.1016","volume":"157","author":[{"given":"Mio","family":"Ishibashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michishige","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho-ichi","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Hasumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Nobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2024.12.004_bib1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/ceo.12696","article-title":"Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review","volume":"44","author":"Ting","year":"2016","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jphs.2024.12.004_bib2","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045 systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jphs.2024.12.004_bib3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jphs.2024.12.004_bib4","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jphs.2024.12.004_bib5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.08.001","article-title":"The progress in understanding and treatment of diabetic retinopathy","volume":"51","author":"Stitt","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jphs.2024.12.004_bib6","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jphs.2024.12.004_bib7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4239\/wjd.v6.i3.489","article-title":"Diabetic retinopathy - ocular complications of diabetes mellitus","volume":"6","author":"Nentwich","year":"2015","journal-title":"World J Diabetes"},{"key":"10.1016\/j.jphs.2024.12.004_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.visres.2017.04.003","article-title":"The pathology associated with diabetic retinopathy","volume":"139","author":"Lechner","year":"2017","journal-title":"Vision Res"},{"key":"10.1016\/j.jphs.2024.12.004_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101799","article-title":"Oxidative stress and diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications","volume":"37","author":"Kang","year":"2020","journal-title":"Redox Biol"},{"key":"10.1016\/j.jphs.2024.12.004_bib10","article-title":"Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy","volume":"2007","author":"Kern","year":"2007","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/j.jphs.2024.12.004_bib11","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/ijms19061816","article-title":"Diabetic retinopathy: pathophysiology and treatments","volume":"19","author":"Wang","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jphs.2024.12.004_bib12","article-title":"Diabetic retinopathy: looking forward to 2030","volume":"13","author":"Tan","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jphs.2024.12.004_bib13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5114\/ceji.2022.112993","article-title":"Novel therapies for diabetic retinopathy","volume":"47","author":"Kupis","year":"2022","journal-title":"Cent Eur J Immunol"},{"key":"10.1016\/j.jphs.2024.12.004_bib14","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3390\/ijms22020954","article-title":"Impact of SMTP targeting plasminogen and soluble epoxide hydrolase on thrombolysis, inflammation, and ischemic stroke","volume":"22","author":"Hasumi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jphs.2024.12.004_bib15","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1111\/j.1742-4658.2010.07783.x","article-title":"Small-molecule modulators of zymogen activation in the fibrinolytic and coagulation systems","volume":"277","author":"Hasumi","year":"2010","journal-title":"FEBS J"},{"key":"10.1016\/j.jphs.2024.12.004_bib16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2174\/1381612825666190319115018","article-title":"Thrombolytic therapy for acute ischemic stroke: past and future","volume":"25","author":"Shibata","year":"2019","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.jphs.2024.12.004_bib17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neulet.2011.08.018","article-title":"Stachybotrys microspora triprenyl phenol-7, a novel fibrinolytic agent, suppresses superoxide production, matrix metalloproteinase-9 expression, and thereby attenuates ischemia\/reperfusion injury in rat brain","volume":"503","author":"Akamatsu","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jphs.2024.12.004_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1254\/jphs.10131FP","article-title":"A novel embolic model of cerebral infarction and evaluation of Stachybotrys microspora triprenyl phenol-7 (SMTP-7), a novel fungal triprenyl phenol metabolite","volume":"114","author":"Hashimoto","year":"2010","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jphs.2024.12.004_bib19","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.06.039","article-title":"Antineuroinflammatory effect of SMTP-7 in ischemic mice","volume":"27","author":"Huang","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jphs.2024.12.004_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/jcbfm.2013.191","article-title":"SMTP-7, a novel small-molecule thrombolytic for ischemic stroke: a study in rodents and primates","volume":"34","author":"Sawada","year":"2014","journal-title":"J Cerebr Blood Flow Metabol"},{"key":"10.1016\/j.jphs.2024.12.004_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00210-010-0542-5","article-title":"A novel finding of a low-molecular-weight compound, SMTP-7, having thrombolytic and anti-inflammatory effects in cerebral infarction of mice","volume":"382","author":"Shibata","year":"2010","journal-title":"N Schmied Arch Pharmacol"},{"key":"10.1016\/j.jphs.2024.12.004_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.448","article-title":"Efficacy of SMTP-7, a small-molecule anti-inflammatory thrombolytic, in embolic stroke in monkeys","volume":"6","author":"Suzuki","year":"2018","journal-title":"Pharmacology Research & Perspectives"},{"key":"10.1016\/j.jphs.2024.12.004_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174496","article-title":"Potent efficacy of Stachybotrys microspora triprenyl phenol-7, a small molecule having anti-inflammatory and antioxidant activities, in a mouse model of acute kidney injury","volume":"910","author":"Shibata","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2024.12.004_bib24","article-title":"SMTP-44D improves diabetic neuropathy symptoms in mice through its antioxidant and anti-inflammatory activities","volume":"6","author":"Shinouchi","year":"2020","journal-title":"Pharmacology Research & Perspectives"},{"key":"10.1016\/j.jphs.2024.12.004_bib25","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/jnr.24326","article-title":"Neuroprotective effects of SMTP-44D in mice stroke model in relation to neurovascular unit and trophic coupling","volume":"96","author":"Shi","year":"2018","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jphs.2024.12.004_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/17425255.2021.1853705","article-title":"The role of cytochrome P450 (CYP) enzymes in hyperoxic lung injury","volume":"17","author":"Stading","year":"2021","journal-title":"Expet Opin Drug Metabol Toxicol"},{"key":"10.1016\/j.jphs.2024.12.004_bib27","first-page":"1629","article-title":"Comparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop","volume":"16","author":"Kern","year":"2010","journal-title":"Mol Vis"},{"key":"10.1016\/j.jphs.2024.12.004_bib28","first-page":"3972","article-title":"Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia","volume":"41","author":"Kern","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jphs.2024.12.004_bib29","doi-asserted-by":"crossref","first-page":"6505","DOI":"10.3390\/ijms24076505","article-title":"SMTP-44D inhibits atherosclerotic plaque formation in apolipoprotein-E null mice partly by suppressing the AGEs-RAGE Axis","volume":"24","author":"Terasaki","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jphs.2024.12.004_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11892-017-0913-0","article-title":"Animal models of diabetic retinopathy","volume":"17","author":"Olivares","year":"2017","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/j.jphs.2024.12.004_bib31","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1006\/exer.2002.1170","article-title":"Early retinal damage in experimental diabetes: electroretinographical and morphological observations","volume":"74","author":"Li","year":"2002","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jphs.2024.12.004_bib32","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0042-6989(01)00026-8","article-title":"On-bipolar cells and depolarising third-order neurons as the origin of the ERG-b-wave in the RCS rat","volume":"41","author":"Wurziger","year":"2001","journal-title":"Vis Res"},{"key":"10.1016\/j.jphs.2024.12.004_bib33","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1016\/S0021-9258(18)99007-1","article-title":"Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo","volume":"266","author":"Dyer","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jphs.2024.12.004_bib34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-4800(03)00035-2","article-title":"The role of advanced glycation in the pathogenesis of diabetic retinopathy","volume":"75","author":"Stitt","year":"2003","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.jphs.2024.12.004_bib35","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.exer.2005.09.022","article-title":"Upregulation of RAGE and its ligands in proliferative retinal disease","volume":"82","author":"Pachydaki","year":"2006","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jphs.2024.12.004_bib36","first-page":"7","article-title":"Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy","volume":"25","author":"Yoshida","year":"2009","journal-title":"Diabetes Mttabolism Res Rev"},{"key":"10.1016\/j.jphs.2024.12.004_bib37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000440768","article-title":"DNA aptamer raised against advanced glycation end products prevents abnormalities in electroretinograms of experimental diabetic retinopathy","volume":"54","author":"Maeda","year":"2015","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.jphs.2024.12.004_bib38","first-page":"1559","article-title":"Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy","volume":"54","author":"Krady","year":"2005","journal-title":"Pharmacol Therapeut"},{"key":"10.1016\/j.jphs.2024.12.004_bib39","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.lfs.2006.03.020","article-title":"Advanced glycation end-products induce apoptosis involving the signaling pathways of oxidative stress in bovine retinal pericytes","volume":"79","author":"Chen","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.jphs.2024.12.004_bib40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1074\/jbc.M602110200","article-title":"Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression","volume":"281","author":"Yamagishi","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jphs.2024.12.004_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/iovs.61.6.4","article-title":"Inhibiting NF-\u03baB signaling activation reduces retinal neovascularization by promoting a polarization shift in macrophages","volume":"61","author":"Sui","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jphs.2024.12.004_bib42","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/cr.2010.178","article-title":"Crosstalk of reactive oxygen species and NF-\u03baB signaling","volume":"21","author":"Morgan","year":"2011","journal-title":"Cell Res"},{"key":"10.1016\/j.jphs.2024.12.004_bib43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2337\/dbi16-0047","article-title":"M\u00fcller cell\u2013microglia cross talk drives neuroinflammation in diabetic retinopathy","volume":"66","author":"Abocouwer","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.jphs.2024.12.004_bib44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.lfs.2016.08.001","article-title":"The importance of glial cells in the homeostasis of the retinal microenvironment and their pivotal role in the course of diabetic retinopathy","volume":"162","author":"Sorrentino","year":"2016","journal-title":"Life Sci"},{"key":"10.1016\/j.jphs.2024.12.004_bib45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12929-024-01036-3","article-title":"Contribution of extracellular vesicles for the pathogenesis of retinal diseases: shedding light on blood-retinal barrier dysfunction","volume":"31","author":"Martins","year":"2024","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jphs.2024.12.004_bib46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12938-023-01194-9","article-title":"RAGE plays key role in diabetic retinopathy: a review","volume":"22","author":"Lu","year":"2023","journal-title":"Biomed Eng Online"},{"key":"10.1016\/j.jphs.2024.12.004_bib47","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000055493","article-title":"Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retinopathy","volume":"30","author":"Segawa","year":"1998","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.jphs.2024.12.004_bib48","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.mvr.2011.09.008","article-title":"High glucose impairs EDHF-mediated dilation of coronary arterioles via reduced cytochrome P450 activity","volume":"82","author":"Tsai","year":"2011","journal-title":"Microvasc Res"},{"key":"10.1016\/j.jphs.2024.12.004_bib49","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.2337\/db10-0110","article-title":"Profile of lipid and protein autacoids in diabetic vitreous correlates with the progression of diabetic retinopathy","volume":"59","author":"Schwartzman","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.jphs.2024.12.004_bib50","doi-asserted-by":"crossref","first-page":"14189","DOI":"10.1074\/jbc.M113.458414","article-title":"Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue","volume":"288","author":"Cherm","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jphs.2024.12.004_bib51","doi-asserted-by":"crossref","first-page":"9677","DOI":"10.1038\/s41598-021-89000-1","article-title":"Cytochrome P450-epoxygenated fatty acids inhibit M\u00fcller glial inflammation","volume":"11","author":"Ontko","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jphs.2024.12.004_bib52","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.3390\/ijms23095187","article-title":"SMTP-44D exerts antioxidant and anti-inflammatory effects through its soluble epoxide hydrolase inhibitory action in immortalized mouse Schwann cells upon high glucose treatment","volume":"9","author":"Shinouchi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jphs.2024.12.004_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2020.111149","article-title":"Epoxyeicosatrienoic acids improve glucose homeostasis by preventing NF-\u03baB-mediated transcription of SGLT2 in renal tubular epithelial cells","volume":"523","author":"Fu","year":"2021","journal-title":"Mol Cell Endocrinol"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S134786132400080X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S134786132400080X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T22:03:24Z","timestamp":1737324204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S134786132400080X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S134786132400080X"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2024.12.004","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SMTP-44D alleviates diabetic retinopathy by suppressing inflammation and oxidative stress in in vivo and in vitro models","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2024.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}